{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LbKhrIJDA","lastupdate":"2022-09-05T00:00:00.000Z","update_date":"2022-09-05T00:00:00.000Z","lastModified":"Feb 20, 2025","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"adva-biotechnology","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$vLdOCDUMufkp4dclkUWZmAYJv5X8BBBxY1r3QxYiiT9HMEFUpEMkEt","name":"ADVA Biotechnology","oneliner":"Automated Platform for Autologous Cell Manufacturing","registrar":"515528065","website":"https://www.advabio.com/","careerspage":"https://www.advabio.com","founded_month":9,"founded_year":2016,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UC-MHD-u3j_vRlBMmK-W8Ndg","facebook":"","linkedin":"https://www.linkedin.com/company/30096447","instagram":""},"social":["https://www.linkedin.com/company/30096447","https://www.youtube.com/channel/UC-MHD-u3j_vRlBMmK-W8Ndg"],"flattenedsociallinks":"https://www.linkedin.com/company/30096447|https://www.youtube.com/channel/UC-MHD-u3j_vRlBMmK-W8Ndg","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":23,"patent":0,"raised":385000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["ADVA-Biotechnology","ADVA.Biotechnology"],"about":"ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution. \r\n\r\nADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability, reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"XKBtyYCZfpSpJrcN0OALuLJ0A9ALjUPqXNlP9V1E44NZS5y5iYYseL","city":"פארק תעשיות בר-לב","type":null,"address":"Bar Lev Industrials Park, Israel","placeid":null,"notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"oPZ8rtbRWHI32cQZUDPHgDBsTWHd7QmGCAoeDEHEwVym8pc66pDgyv","date":"Aug 3, 2022","link":"https://www.companyinsight.co.uk/lonza-and-adva-biotechnology-ltd-agree-to-expand-availability-and-use-of-automated-bioreactors-with-license-to-lonzas-patents/","source":"www.companyinsight.co.uk","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"0PwyTZF3M7LHteySo5jQ1xvr9facdWZ9dD4JeD3FutokFLOzs2cvQD","news_summary":"Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with License to Lonza's Patents | Company Insight","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"3fa85270-07a8-48d4-9f2f-baea47a9320d","date":"Jan 14, 2021","link":"https://www.jpost.com/health-science/personalized-cancer-treatments-no-longer-a-dream-with-new-medical-tech-655399","source":"www.jpost.com","visible":1,"analysis":{"tags":["cancer cure","CAR-T cells","genetic engineering","immunotherapy","ADVA X3","pharmaceutical industry"],"company":"ADVA Biotechnology","layoffs":null,"summary":"ADVA Biotechnology has developed the ADVA X3, a device that can create CAR-T cells, a partial cure for certain types of cancer. The device automates the process of producing CAR-T cells, making it more accessible and cost-effective. Currently, the treatment is only available to a small group of terminally ill cancer patients due to cost, logistics, and lack of technology. The ADVA X3 aims to revolutionize the industry by allowing hospitals to produce customized drugs for each patient, reducing manufacturing costs, and increasing accessibility. ADVA Biotechnology has received positive feedback from medical professionals, industry leaders, and investors, and plans to introduce the device into hospitals and medical centers in Israel and internationally.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["cancer cure","CAR-T cells","genetic engineering","ADVA X3","pharmaceutical industry"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"s7XftI1j66Va2bLi0AlvvnTkjUN63qxT83e4IP8VlDr1yBbv8gMu8Y","news_summary":"https://www.jpost.com/health-science/personalized-cancer-treatments-no-longer-a-dream-with-new-medical-tech-655399","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"58ff77e7-768d-4583-a87e-6d468c052632","date":"Sep 25, 2020","link":"https://www.jpost.com/health-science/adva-biotechnology-643385","source":"www.jpost.com","visible":1,"analysis":{"tags":"disruptive technology, personalized medicine, cell therapy","company":"ADVA Biotechnology","layoffs":null,"summary":"ADVA Biotechnology has developed solutions for manufacturing personalized cell therapy for specific patients at bedside. The founder and CEO, Dr. Ohad Karnieli, spoke about the revolutionary change in medicine through personalized medicine and the need for enabling technology to bring it to patients in a cost-efficient manner.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["disruptive technology","personalized medicine","cell therapy","manufacturing","cost-efficiency"],"date_of_event":"September 25, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"28pjZg1Qnh0CQGH6vV8CuocZQXT0JsELVN0TPTzjm6RhVuLKGHDIci","news_summary":"https://www.jpost.com/health-science/adva-biotechnology-643385","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"befffa8d-b03e-41d2-b74e-6a42499821a8","date":"Feb 6, 2018","link":"https://www.globenewswire.com/news-release/2018/02/06/1333722/0/en/Orgenesis-and-Adva-Biotechnology-to-Develop-and-Distribute-Advanced-Automated-Culturing-System-for-Cell-Therapy-Manufacturing.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"regenerative medicine","company":"Orgenesis Inc.","layoffs":null,"summary":"Orgenesis Inc. has entered into an agreement with Adva Biotechnology Ltd. for the development of an automated culturing system for use in contract manufacturing services and therapeutic development. The system has the potential to enable cost-efficient and automated manufacturing for autologous cell therapies. Orgenesis intends to develop this technology through its joint venture with Atvio Biotech Ltd. and distribute the systems globally through MaSTherCell and its CDMO partners. The collaboration will be financed by Orgenesis and is part of their commitment to innovation in the field of autologous cell therapies. The system is designed to allow single-use, closed end-to-end automated manufacturing of suspension cells. Once fully developed, the system should significantly reduce costs and enhance manufacturing capacity for cell therapy companies.","partners":["Adva Biotechnology Ltd."],"customers":null,"investors":null,"confidence":8,"key_topics":["automated culturing system","cell therapy development","manufacturing","joint venture","cost-efficient"],"date_of_event":"February 6, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"iwLeRG9JYd283mYSXP8e0RCgeM4iqrqA3Vwrg2zOC4vkw6UfOBBe0E","news_summary":"Orgenesis and Adva Biotechnology to Develop and Distribute Advanced Automated Culturing System for Cell Therapy Manufacturing","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":4,"techcommunityinvolvement":null,"mediagallery":[{"id":"155ee70f-590a-4726-8241-c0401d9748cc","timestamp":"2021-04-05 10:17:13.000000","resources_type":2,"resources_title":"Board Member's TV Interview","resources_file_name":"toWA14NeoKg","alt":"Board Member's TV Interview logo","imageurl":"https://img.youtube.com/vi/toWA14NeoKg/0.jpg","url":"http://youtu.be/toWA14NeoKg"},{"id":"3ebf2aab-d827-48e7-92ce-ee7a6f0d266c","timestamp":"2020-02-25 06:30:59.000000","resources_type":1,"resources_title":"Adva1","resources_file_name":"$oNIq9GNLTs9VgD1zQtcY88hDIU8A0vWZg6kgSFJFl1QloSNZUwTDz8","alt":"Adva1 logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$oNIq9GNLTs9VgD1zQtcY88hDIU8A0vWZg6kgSFJFl1QloSNZUwTDz8","url":"https://storage.googleapis.com/clean-finder-353810/$oNIq9GNLTs9VgD1zQtcY88hDIU8A0vWZg6kgSFJFl1QloSNZUwTDz8"},{"id":"4bef1fd2-705e-47f7-a413-3377cac2ddff","timestamp":"2020-02-25 06:29:44.000000","resources_type":2,"resources_title":"Adva X3","resources_file_name":"nxxfW01Usjc","alt":"Adva X3 logo","imageurl":"https://img.youtube.com/vi/nxxfW01Usjc/0.jpg","url":"http://youtu.be/nxxfW01Usjc"}],"tags":["medical-technologies","patients","biotechnology","medical-devices","hospitals","cancer","cell-therapy","immunology","manufacturing","genetic-engineering","automation","monitoring"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Adva_X3"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$385K","totalrounds":3,"fundingstage":"Seed","totalfunding":"$385K","publicinvestors":2,"lastpublicfunding":385000,"totalpublicrounds":3,"totalpublicfunding":385000},"team":[{"name":"Tal Slonim","email":"tal@advabio.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4La4tYoJDA","bounced":false,"claimed":0,"founder":1,"urlname":"tal-slonim","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg1tS1kAkM","position":"Co-founder & Board Member","last_name":"Slonim","claimtoken":"46d16d521aad301a2460aca61e59be9c320c83687a9101062be22920a5b63164","first_name":"Tal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tal-slonim-2a321580/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"TS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ron  Elazary-Vulcani","email":"ron@advabio.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Laq0p4KDA","bounced":true,"claimed":0,"founder":1,"urlname":"ron-elazary-vulcani","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg5quUlwoM","position":"Co-founder & Board Member","last_name":" Elazary-Vulcani","claimtoken":"7dYFZQBkKWyGukUXM74hODg4Z1aIIajZY6Nix8WinfSscO0PGDlqfJ","first_name":"Ron","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-05 19:32:40.000000","initials":"R ","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Barbara  Paldus","email":"barbara@advabio.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OaGqokJDA","bounced":true,"claimed":0,"founder":1,"urlname":"barbara-paldus","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgtv_2lwsM","position":"Co-founder & Board Member","last_name":"Paldus","claimtoken":"bc6313ec9ee91f9a0925cfcd1876741b4053f92f6dd58e39c59af71df7eb7b69","first_name":"Barbara ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/barbara-paldus-a084831/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-04-05 10:19:30.000000","initials":"BP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ohad Karnieli","email":"ohad@advabio.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4JbB56YKDA","bounced":false,"claimed":0,"founder":1,"urlname":"ohad-karnieli","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgtr_fqgkM","position":"Founder & CEO","last_name":"Karnieli","claimtoken":"NrQIRA6DfOj8ladjBMpjSM59add371AVzy1Ppx1KFq0Qfe98erfXox","first_name":"Ohad","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ohadkarnieli/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-05 19:32:47.000000","initials":"OK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ofra  Toledo","email":"ofra@advabio.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Lax35oJDA","bounced":false,"claimed":0,"founder":0,"urlname":"ofra-toledo","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgtr_fqgsM","position":"VP Business Development","last_name":"Toledo","claimtoken":"0s1NJKlnyiRFRZ9wIVlbscxLeZWTB7jb5yC6ig8mskTiTG4PMtcQ2Y","first_name":"Ofra ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ofra-toledo/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-05 19:32:50.000000","initials":"OT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Noam  Bercovich","email":"noam@advabio.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4JbtjZQJDA","bounced":false,"claimed":0,"founder":0,"urlname":"noam-bercovich","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDglu3_nAsM","position":"VP Development","last_name":" Bercovich","claimtoken":"ffBTcKc9l6mBzO8f22b4NCfugtEYpVQ0uysM1JRDWHj6l03rTLwWbQ","first_name":"Noam","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/noam-bercovich-588a648b/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-05 19:32:44.000000","initials":"N ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPu-g88JDA","fullname":"Maor Perlov"},"biverifydate":"2020-03-08T00:00:00.000Z","crunchbaseid":"","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2020-02-25T00:00:00.000Z","biverification":"Maor Perlov","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"5emO4b6u4Wd8XanyydNi8H3kM3IYic7stOKaT4kRaiyJag4j2GThIt","date":"Sep 2024","amount":"$385K","source":"Israel Innovation Authority","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-innovation-authority-1","logokey":"$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","tagline":"Governmental grant for POC ","urlname":"/investor_page/israel-innovation-authority-1","isisraeli":1,"investorid":"8TrglTPuxDd2ABfwzfoRPSHOLbGlGXhvTxe0CF3zKPbddG3xPprg1h","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"EU7zwbg09ImULMuCjH9RBipXI4M5ocweZn02DnbgWAL81UwiNHjeYc","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":385000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDw3NX3CQw","date":"Jun 2021","amount":"Undisclosed","source":"Brandon Lurie, from Aviv Growth Partners, https://www.crunchbase.com/organization/adva-biotechnologies/company_financials","eventtype":"FundingRoundEvent","investment":[{"name":"AGP Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/agp-ventures","logokey":"$l7x2wlbzNb5KG0BDPmZPOCP5GbnhYETpEk3NjJuBIzEaz3qeBIfaBl","tagline":null,"urlname":"/investor_page/agp-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Iui2qgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0496c97c-af1e-4f82-8c05-a24f82baa714","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$l7x2wlbzNb5KG0BDPmZPOCP5GbnhYETpEk3NjJuBIzEaz3qeBIfaBl","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODtx4eJCgw","date":"Aug 2020","amount":"Undisclosed","source":"https://www.exitvalley.com/Projects/advabio/?WebLang=EN","eventtype":"FundingRoundEvent","investment":[{"name":"ExitValley","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/exitvalley","logokey":"$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","tagline":null,"urlname":"/investor_page/exitvalley","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ2Kp4EKDA","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"66a66d30-582a-4c11-a5c9-e9f865f655a3","fundingsubtype":"Equity Crowdfunding","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Equity crowdfunding","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/2016","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"ADVA Biotechnology","logourl":"https://storage.googleapis.com/clean-finder-353810/$vLdOCDUMufkp4dclkUWZmAYJv5X8BBBxY1r3QxYiiT9HMEFUpEMkEt","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$vLdOCDUMufkp4dclkUWZmAYJv5X8BBBxY1r3QxYiiT9HMEFUpEMkEt","seoabout":"ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing c...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Life Sciences","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Cells","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Cells"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Cells"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDw3NX3CQw","date":"Jun 2021","amount":"Undisclosed","source":"Brandon Lurie, from Aviv Growth Partners, https://www.crunchbase.com/organization/adva-biotechnologies/company_financials","eventtype":"FundingRoundEvent","investment":[{"name":"AGP Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/agp-ventures","logokey":"$l7x2wlbzNb5KG0BDPmZPOCP5GbnhYETpEk3NjJuBIzEaz3qeBIfaBl","tagline":null,"urlname":"/investor_page/agp-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Iui2qgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0496c97c-af1e-4f82-8c05-a24f82baa714","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$l7x2wlbzNb5KG0BDPmZPOCP5GbnhYETpEk3NjJuBIzEaz3qeBIfaBl","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODtx4eJCgw","date":"Aug 2020","amount":"Undisclosed","source":"https://www.exitvalley.com/Projects/advabio/?WebLang=EN","eventtype":"FundingRoundEvent","investment":[{"name":"ExitValley","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/exitvalley","logokey":"$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","tagline":null,"urlname":"/investor_page/exitvalley","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ2Kp4EKDA","fundingtype":"Equity Crowdfunding","leadpartner":null,"investmentid":"66a66d30-582a-4c11-a5c9-e9f865f655a3","fundingsubtype":"Equity Crowdfunding","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$pOT4GzAxUYSE4XovvswdvrLng8TJdTlPvN6lBPUe9xjU5msj7uXuY4","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Equity crowdfunding","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"5emO4b6u4Wd8XanyydNi8H3kM3IYic7stOKaT4kRaiyJag4j2GThIt","date":"Sep 2024","amount":"$385K","source":"Israel Innovation Authority","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-innovation-authority-1","logokey":"$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","tagline":"Governmental grant for POC ","urlname":"/investor_page/israel-innovation-authority-1","isisraeli":1,"investorid":"8TrglTPuxDd2ABfwzfoRPSHOLbGlGXhvTxe0CF3zKPbddG3xPprg1h","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"EU7zwbg09ImULMuCjH9RBipXI4M5ocweZn02DnbgWAL81UwiNHjeYc","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":385000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}